Drugdiscovery >> Clinical Trials >> News
6853
Views
New succes on Phase II trial of a new GBM vaccine - drugdiscovery.com
New succes on Phase II trial of a new GBM vaccine - drugdiscovery.com


ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so the placebo-controlled phase II trial is a big step-forward in this field.
Read More >>


Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial. - January 9, 2014
Related Articles
4859
Views
GSK’s  malaria vaccine candidate shows promise in Phase 3 trial GSK’s malaria vaccine candidate shows promise in Phase 3 trial
According to the results of a large-scale Phase 3 trial, the vaccine candidate RTS,S, showed efficient at protecting young children and infants from clinical malaria up to 18 months after vaccination. Read More >>

Tags: GSK, malaria vaccine, malaria, RTS,S, clinical trial

4464
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

7751
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

6185
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

2208
Views
MAGE-A3 immunotherapy fails to slow melanoma in Phase 3 trial MAGE-A3 immunotherapy fails to slow melanoma in Phase 3 trial
GlaxoSmithKline’s investigational melanoma vaccine failed to slow progression of advanced melanoma (the first of two co-primary endpoints) in a randomized, phase 3 clinical trial. Follow-up in the t Read More >>

Tags: MAGE-A3, immunotherapy, melanoma, vaccine, Glaxo, clinical trial

1717
Views
Vaccine pill instead of injection Vaccine pill instead of injection
A biotechnology company named Vaxart aims to develop vaccines that would be taken as pills instead the common way. The phase I human clinical trial for H1N1 seasonal flu and H5n1 avian flu is in prog Read More >>

Tags: Vaxart,vaccine, pill, clinical trial, H1N1, H5n1

5560
Views
Edison Pharmaceuticals announces Phase 2 trial of EPI-743 Edison Pharmaceuticals announces Phase 2 trial of EPI-743
A trial is a double-blind, placebo-controlled crossover study of EPI-743 in patients with defined or undefined genetic diagnoses that feature cellular oxidation/reduction or energy production defects. Read More >>

Tags: Edison, clinical trial, EPI-743, disorders of energy utilization, oxidation-reduction

2756
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

3295
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

5173
Views
Patient enrollment in Phase 3 EPIC trial of Iclusig for CML Patient enrollment in Phase 3 EPIC trial of Iclusig for CML
ARIAD Pharmaceuticals’s drug Iclusig (ponatinib) will be compared for efficasy with imatinib in a Phase 3 trial in adult patients with newly diagnosed chronic myeloid leukemia (CML). ARIAD has enrol Read More >>

Tags: Ariad, iclusig, ponatinib, EPIC, clinical trial, CML, chronic myeloid leukemia

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013